Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Meeting Report
  • Published:

The eighth international childhood acute lymphoblastic leukemia workshop (‘Ponte di Legno meeting’) report: Vienna, Austria, April 27–28, 2005

Leukemia volume 20, pages 9–17 (2006)Cite this article

Abstract

The International Acute Lymphoblastic Leukemia Working Group, the so-called ‘Ponte di Legno Workshop’ has led to substantial progress in international collaboration in leukemia research. On April 27–28, 2005, the 8th Meeting was held in Vienna, Austria, to continue the discussions about special common treatment elements in randomized clinical trials, ethical and clinical aspects of therapy. Furthermore, collaborative projects of clinical relevance with special emphasis on rare genetic subtypes of Childhood ALL were established. The following report summarizes the achievements and aspects of possible future cooperation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pui CH, Evans WE, Gilbert JR . Meeting report: international childhood ALL workshop: memphis, TN, 3–4 December 1997. Leukemia 1998; 12: 1313–1318.

    Article  CAS  PubMed  Google Scholar 

  2. Pui CH, Schrappe M, Camitta B . Normal and malignant hemopoiesis: spotlight on long-term results of pediatric ALL clinical trials from study 12 groups world wide. Leukemia 2000; 14: 2193–2320.

    Article  PubMed  Google Scholar 

  3. Pui CH, Ribeiro RC . International collaboration on childhood leukemia. Int J Hematol 2003; 78: 383–389.

    Article  PubMed  Google Scholar 

  4. Aricó M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000; 342: 998–1006.

    Article  PubMed  Google Scholar 

  5. Pui CH, Sallan S, Relling MV, Masera G, Evans WE . International childhood acute lymphoblastic leukemia workshop: Sausalito, CA, 30 November–1 December 2000. Leukemia 2001; 15: 707–715.

    Article  CAS  PubMed  Google Scholar 

  6. Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909–1915.

    Article  PubMed  Google Scholar 

  7. Pui CH, Chessell JM, Camitta B, Baruchel A, Biondi A, Boyett JM et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003; 17: 700–706.

    Article  CAS  PubMed  Google Scholar 

  8. Gadner H, Haas OH, Masera G, Pui C-H, Schrappe M . ‘Ponte di Legno’ working group – report on the fifth international childhood acute lymphoblastic leukemia workshop: Vienna, Austria, 29 April – 1 May 2002. Leukemia 2003; 17: 798–803.

    Article  CAS  PubMed  Google Scholar 

  9. Heerema NA, Harbott J, Galimberti S, Valsecchi MG, Camitta BM, Gaynon PS et al. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are non-random and may be associated with outcome. Leukemia 2004; 18: 693–702.

    Article  CAS  PubMed  Google Scholar 

  10. Pui CH, Schrappe M, Masera G, Nachman J, Gadner H, Eden OB et al. Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop. Leukemia 2004; 18: 1043–1053.

    Article  PubMed  Google Scholar 

  11. Aricó M, Baruchel A, Bertrand Y, Biondi A, Conter V, Eden T et al. The seventh international childhood acute lymphoblastic leukemia worskshop report: Palermo, Italy, January 29–30, 2005. Leukemia 2005; 19: 1145–1152.

    Article  PubMed  Google Scholar 

  12. Vieira Pinheiro JP, Boos J . The best way to use asparaginase in childhood acute lymphoblastic leukaemia – still to be defined? Br J Haematol 2004; 125: 117–127.

    Article  Google Scholar 

  13. Woo MH, Hak LJ, Storm MC, Evans WE, Sandlund JT, Rivera GK et al. Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia 1998; 12: 1527–1533.

    Article  CAS  PubMed  Google Scholar 

  14. Woo MH, Hak LJ, Storm MC, Sandlund JT, Ribeiro RC, Rivera GK et al. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 2000; 18: 1525–1532.

    Article  CAS  PubMed  Google Scholar 

  15. Hak LJ, Relling MV, Cheng C, Pei D, Wang B, Sandlund JT et al. Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia. Leukemia 2004; 18: 1072–1077.

    Article  CAS  PubMed  Google Scholar 

  16. Avramis VI, Sencer S, Periclou AP, Sather H, Bostrom BC, Cohen LJ et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 2002; 99: 1986–1994.

    Article  CAS  PubMed  Google Scholar 

  17. Vieira Pinheiro JP, Lanvers C, Würthwein G, Beier R, Casimiro Da Palma J, Von Stackelberg A et al. Drug monitoring of PEG-asparaingase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Leuk Lymphoma 2002; 43: 1911–1920.

    Article  CAS  PubMed  Google Scholar 

  18. Hawkins DS, Park JR, Thomson BG, Felgenhauer JL, Holcenberg JS, Panosyan EH et al. Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. Clin Cancer Res 2004; 10: 5335–5341.

    Article  CAS  PubMed  Google Scholar 

  19. Harms DO, Janka-Schaub GE . Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukemia 2000; 14: 2234–2239.

    Article  CAS  PubMed  Google Scholar 

  20. Ng A, Taylor GM, Eden OB . Treatment related Leukaemia – a clinical and scientific challenge. Cancer Treat Rev 2000; 26: 377–391.

    Article  CAS  PubMed  Google Scholar 

  21. Thomsen JB, Schroder H, Kristinsson J, Madsen B, Szumlanski C, Weinshilboum R et al. Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism. Cancer 1999; 86: 1080–1086.

    Article  CAS  Google Scholar 

  22. Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354: 34–39.

    Article  CAS  PubMed  Google Scholar 

  23. Masera G, Eden T, Schrappe M, Nachman J, Gadner H, Gaynon P et al. Position Statement: statement by members of the Ponte di Legno Group on the Rights of children to have full access to essential treatment for acute lymphoblastic leukaemia. Pediatr Blood Cancer 2004; 43: 103–104.

    Article  PubMed  Google Scholar 

  24. Eden T, Pui CH, Schrappe M, Tognoni G, Masera G . All children have the right to full access to treatment for cancer. Lancet 2004; 364: 1121–1122.

    Article  PubMed  Google Scholar 

  25. Global Action Against Cancer. World Health Organisation and UICC, 2003 ISBN 92 4 1590726.

  26. Barr RD, Sala A, Masera G, Mato G, Antillon F, Castillo L et al. A formulary for pediatric oncology in developing countries. Pediatr Blood Cancer 2005; 44: 433–435.

    Article  PubMed  Google Scholar 

  27. Harewood L, Robinson H, Harris R, Al Obaidi MJ, Jalali GR, Martineau M et al. Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia 2003; 17: 547–553.

    Article  CAS  PubMed  Google Scholar 

  28. Robinson HM, Broadfield ZJ, Cheung KL, Harewood L, Harris RL, Jalali GR et al. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome. Leukemia 2003; 17: 2249–2250.

    Article  CAS  PubMed  Google Scholar 

  29. Hunger SP . Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 1996; 87: 1211–1224.

    CAS  PubMed  Google Scholar 

  30. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000; 95: 3310–3322.

    CAS  PubMed  Google Scholar 

  31. Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Leukemia 2000; 14: 2223–2233.

    Article  CAS  PubMed  Google Scholar 

  32. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmudsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 2000; 14: 2267–2275.

    Article  CAS  PubMed  Google Scholar 

  33. Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA . Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986–1994. Leukemia 2000; 14: 2276–2285.

    Article  CAS  PubMed  Google Scholar 

  34. Pui C-H, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC et al. Long-term results of total therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia 2000; 14: 2286–2294.

    Article  CAS  PubMed  Google Scholar 

  35. Eden OB, Harrison G, Richards S, Lilleyman JS, Bailey CC, Chessells JM et al. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980–1997. Leukemia 2000; 14: 2307–2320.

    Article  CAS  PubMed  Google Scholar 

  36. Pui C-H, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA 2003; 290: 2001–2007.

    Article  CAS  PubMed  Google Scholar 

  37. Kager L, Cheok M, Yang W, Zaza G, Cheng Q, Panetta JC et al. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. J Clin Invest 2005; 115: 110–117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Secker-Walker LM, Berger R, Fenaux P, Lai JL, Nelken B, Garson M et al. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 1992; 6: 363–369.

    CAS  PubMed  Google Scholar 

  39. Pui C-H, Raimondi SC, Hancock ML, Rivera GK, Ribeiro RC, Mahmoud HH et al. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative. J Clin Oncol 1994; 12: 2601–2606.

    Article  CAS  PubMed  Google Scholar 

  40. Uckun FM, Sensel MG, Sather HN, Gaynon PS, Arthur DC, Lange BJ et al. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 527–535.

    Article  CAS  PubMed  Google Scholar 

  41. Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffe M, Della Valle V, Monni R et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001; 15: 1495–1504.

    Article  CAS  PubMed  Google Scholar 

  42. Su XY, Busson M, Della Valle V, Ballerini P, Dastugue N, Talmant P et al. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2004; 41: 243–249.

    Article  CAS  PubMed  Google Scholar 

  43. Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 2002; 100: 991–997.

    Article  CAS  PubMed  Google Scholar 

  44. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EM, Vang-Nielsen K et al. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 2004; 18: 895–908.

    Article  CAS  PubMed  Google Scholar 

  45. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – a Europe Against Cancer program. Leukemia 2003; 17: 2318–2357.

    Article  CAS  PubMed  Google Scholar 

  46. Berger R, Dastugue N, Busson M, van den AJ, Perot C, Ballerini P et al. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Leukemia 2003; 17: 1851–1857.

    Article  CAS  PubMed  Google Scholar 

  47. Cave H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies. Blood 2004; 103: 442–450.

    Article  CAS  PubMed  Google Scholar 

  48. Barber KE, Martineau M, Harewood L, Stewart M, Cameron E, Strefford JC et al. Amplification of the ABL gene in T-cell acute lymphoblastic leukemia. Leukemia 2004; 18: 1153–1156.

    Article  CAS  PubMed  Google Scholar 

  49. Kim HJ, Woo HY, Koo HH, Tak EY, Kim SH . ABL oncogene amplification with p16(INK4a) gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: report of the first case. Am J Hematol 2004; 76: 360–363.

    Article  CAS  PubMed  Google Scholar 

  50. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084–1089.

    Article  CAS  PubMed  Google Scholar 

  51. Zeller BG, Gustafsson E, Forestier J, Abrahamsson N, Clausen J, Heldrup L et al. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br J Haematol 2005; 128: 797–804.

    Article  PubMed  Google Scholar 

  52. Ravindranath Y . Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment. Pediatr Blood Cancer 2005; 44: 1–7.

    Article  PubMed  Google Scholar 

  53. Izraeli S . Congenital syndromes and leukemia: clues to pathogenesis. Rev Clin Exp Hematol 2003; 7: 246–260.

    CAS  PubMed  Google Scholar 

  54. Hitzler JK, Zipursky A . Origins of leukaemia in children with Down syndrome. Nat Rev Cancer 2005; 5: 11–20.

    Article  CAS  PubMed  Google Scholar 

  55. Lange B . The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol 2000; 110: 512–524.

    Article  CAS  PubMed  Google Scholar 

  56. Bassal M, La MK, Whitlock JA, Sather HN, Heerema NA, Gaynon PS et al. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952. Pediatr Blood Cancer 2005; 44: 21–28.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The 8th International Childhood ALL Workshop was made possible by the generous support of: Baxter, Becton-Dickinson Austria, Beiersdorf, Bio Rad Laboratories, Children's Cancer Research Institute, EBEWE Pharma-Austria, Deutsche José Carreras Leukämie-Stiftung e.v., Fresenius Kabi, Merck, Sharp & Dohme, Messer Austria, Pfizer Oncology, Roche, and Wyeth. Preparation of the meeting report was supported in part by the Österreichische Kinderkrebshilfe and private donations to the Children's Cancer Research Institute; the Associazione Italiana Ricerca sul Cancro, Fondazione Tettamanti, and Consiglio Nazionale Ricerche-Ministero Instruzione Universitá Ricerca; the Deutsche Krebshilfe, Bonn, and Madeleine Schickedanz Foundation, Fürth, Germany; Cancer Research UKJ; grants from the US National Institutes of Health (CA-21765, CA-51001, CA-31566, CA-78824, CA-29139, CA-37379, GM-61393, and GM61374); a Center of Excellence grant from the State of Tennessee, and the American Lebanese Syrian Associated Charities (ALSAC). C-H Pui is the American Cancer Society – FM Kirby Clinical Research Professor.

Author information

Authors and Affiliations

  1. Berlin-Frankfurt-Münster Study Group and St Anna Children's Hospital, Vienna, Austria

    H Gadner

  2. Associazione Italiana di Ematologia ed Oncologia Pediatrica and Centro Ricerca M Tettamanti, Clinica Pediatrica, Università Milano-Bicocca, Monza

    G Masera

  3. Italy

    G Masera

  4. Berlin-Frankfurt-Münster Study Group and Children's Hospital, University Medical Center Schleswig-Holstein, Campus Kiel, Germany

    M Schrappe

  5. Medical Research Council/NCRI United Kingdom Acute Lymphoblastic Leukaemia Working Group and The Christie Hospital NHS Trust, Manchester, UK

    T Eden

  6. European Organization for Research and Treatment of Cancer – Childhood Leukemia Cooperative Group and Gent University Hospital, Gent, Belgium

    Y Benoit

  7. National Cancer Research Institute, United Kingdom Childhood Leukaemia Working Party and University of Southampton, UK

    C Harrison

  8. Department of Pediatrics, Hematology and Oncology, Children's Oncology Group and University of Chicago, USA

    J Nachman

  9. St Jude Children's Research Hospital and The University of Tennessee Health Science Center, Memphis, TN, USA

    C-H Pui

Authors
  1. H Gadner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Masera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Schrappe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Eden
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Benoit
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Nachman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C-H Pui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H Gadner.

Additional information

Participating Groups/Institutions (participants):

Associazione Italiana Ematologia ed Oncologia Pediatrica (M Aricó, A Biondi, R Chiesa, V Conter, Masera, G Tognoni, GM Valsecchi), Berlin-Frankfurt-Münster Group (H Gadner, O Haas, J Harbott, R Panzer-Grümayer, H Riehm, M Schrappe, Av Stackelberg, M Stanulla, M Zimmermann), Children's Oncology Group (D Meenakshi, S Hunger, P Gaynon, J Nachman), Cooperative Acute Lymphoblastic Leukemia Study Group (M Horstmann, G Janka), Czech Pediatric Hematology (J Stary, J Trka), Dutch Childhood Oncology Group (M Biehrings), European Organization for Research and Treatment of Cancer – Childhood Leukemia Cooperative Group (Y Benoit, H Cavé, J Otten, S Suciu), French Acute Lymphoblastic Leukemia Study Group (A Baruchel), Japan Association of Childhood Leukemia Study (K Horibe), Medical Research Council/NCRI United Kingdom Acute Lymphoblastic Leukaemia Working Party (B Gibson, T Eden, I Hann, C Harrison), Nordic Society of Pediatric Hematology and Oncology (E Forestier, K Schmiegelow, K Vettenranta), St Jude Children's Research Hospital (S Jeha, CH Pui), Taiwan Pediatric Oncology Group (DC Liang), Tokyo Children's Cancer Study Group (K Koh, A Manabe), Guests: S Izraeli, A Attarbaschi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gadner, H., Masera, G., Schrappe, M. et al. The eighth international childhood acute lymphoblastic leukemia workshop (‘Ponte di Legno meeting’) report: Vienna, Austria, April 27–28, 2005. Leukemia 20, 9–17 (2006). https://doi.org/10.1038/sj.leu.2404016

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404016

Keywords

This article is cited by

Search

Advanced search

Quick links